231 related articles for article (PubMed ID: 10564161)
1. VEGF stimulates tyrosine phosphorylation of beta-catenin and small-pore endothelial barrier dysfunction.
Cohen AW; Carbajal JM; Schaeffer RC
Am J Physiol; 1999 Nov; 277(5):H2038-49. PubMed ID: 10564161
[TBL] [Abstract][Full Text] [Related]
2. Vascular endothelial growth factor stimulates tyrosine phosphorylation and recruitment to new focal adhesions of focal adhesion kinase and paxillin in endothelial cells.
Abedi H; Zachary I
J Biol Chem; 1997 Jun; 272(24):15442-51. PubMed ID: 9182576
[TBL] [Abstract][Full Text] [Related]
3. Upregulation of angiotensin-converting enzyme by vascular endothelial growth factor.
Saijonmaa O; Nyman T; Kosonen R; Fyhrquist F
Am J Physiol Heart Circ Physiol; 2001 Feb; 280(2):H885-91. PubMed ID: 11158990
[TBL] [Abstract][Full Text] [Related]
4. Vascular endothelial growth factor/vascular permeability factor enhances vascular permeability via nitric oxide and prostacyclin.
Murohara T; Horowitz JR; Silver M; Tsurumi Y; Chen D; Sullivan A; Isner JM
Circulation; 1998 Jan 6-13; 97(1):99-107. PubMed ID: 9443437
[TBL] [Abstract][Full Text] [Related]
5. Roles of two VEGF receptors, Flt-1 and KDR, in the signal transduction of VEGF effects in human vascular endothelial cells.
Kanno S; Oda N; Abe M; Terai Y; Ito M; Shitara K; Tabayashi K; Shibuya M; Sato Y
Oncogene; 2000 Apr; 19(17):2138-46. PubMed ID: 10815805
[TBL] [Abstract][Full Text] [Related]
6. Vascular endothelial growth factor (VEGF)-driven actin-based motility is mediated by VEGFR2 and requires concerted activation of stress-activated protein kinase 2 (SAPK2/p38) and geldanamycin-sensitive phosphorylation of focal adhesion kinase.
Rousseau S; Houle F; Kotanides H; Witte L; Waltenberger J; Landry J; Huot J
J Biol Chem; 2000 Apr; 275(14):10661-72. PubMed ID: 10744763
[TBL] [Abstract][Full Text] [Related]
7. Contact inhibition of VEGF-induced proliferation requires vascular endothelial cadherin, beta-catenin, and the phosphatase DEP-1/CD148.
Grazia Lampugnani M; Zanetti A; Corada M; Takahashi T; Balconi G; Breviario F; Orsenigo F; Cattelino A; Kemler R; Daniel TO; Dejana E
J Cell Biol; 2003 May; 161(4):793-804. PubMed ID: 12771128
[TBL] [Abstract][Full Text] [Related]
8. Endothelial contraction and monolayer hyperpermeability are regulated by Src kinase.
Mucha DR; Myers CL; Schaeffer RC
Am J Physiol Heart Circ Physiol; 2003 Mar; 284(3):H994-H1002. PubMed ID: 12456392
[TBL] [Abstract][Full Text] [Related]
9. The counteradhesive protein SPARC regulates an endothelial paracellular pathway through protein tyrosine phosphorylation.
Young BA; Wang P; Goldblum SE
Biochem Biophys Res Commun; 1998 Oct; 251(1):320-7. PubMed ID: 9790954
[TBL] [Abstract][Full Text] [Related]
10. Endotoxin induces endothelial barrier dysfunction through protein tyrosine phosphorylation.
Bannerman DD; Goldblum SE
Am J Physiol; 1997 Jul; 273(1 Pt 1):L217-26. PubMed ID: 9252559
[TBL] [Abstract][Full Text] [Related]
11. Treatment for malignant pleural effusion of human lung adenocarcinoma by inhibition of vascular endothelial growth factor receptor tyrosine kinase phosphorylation.
Yano S; Herbst RS; Shinohara H; Knighton B; Bucana CD; Killion JJ; Wood J; Fidler IJ
Clin Cancer Res; 2000 Mar; 6(3):957-65. PubMed ID: 10741721
[TBL] [Abstract][Full Text] [Related]
12. Vascular endothelial growth factor induces VE-cadherin tyrosine phosphorylation in endothelial cells.
Esser S; Lampugnani MG; Corada M; Dejana E; Risau W
J Cell Sci; 1998 Jul; 111 ( Pt 13)():1853-65. PubMed ID: 9625748
[TBL] [Abstract][Full Text] [Related]
13. The antiangiogenic agent neovastat (AE-941) inhibits vascular endothelial growth factor-mediated biological effects.
Béliveau R; Gingras D; Kruger EA; Lamy S; Sirois P; Simard B; Sirois MG; Tranqui L; Baffert F; Beaulieu E; Dimitriadou V; Pépin MC; Courjal F; Ricard I; Poyet P; Falardeau P; Figg WD; Dupont E
Clin Cancer Res; 2002 Apr; 8(4):1242-50. PubMed ID: 11948139
[TBL] [Abstract][Full Text] [Related]
14. Characterization of vascular endothelial growth factor's effect on the activation of protein kinase C, its isoforms, and endothelial cell growth.
Xia P; Aiello LP; Ishii H; Jiang ZY; Park DJ; Robinson GS; Takagi H; Newsome WP; Jirousek MR; King GL
J Clin Invest; 1996 Nov; 98(9):2018-26. PubMed ID: 8903320
[TBL] [Abstract][Full Text] [Related]
15. Vascular endothelial growth factor expression, beta-catenin tyrosine phosphorylation, and endothelial proliferative behavior: a pathway for transformation?
Ilan N; Tucker A; Madri JA
Lab Invest; 2003 Aug; 83(8):1105-15. PubMed ID: 12920240
[TBL] [Abstract][Full Text] [Related]
16. VEGF-induced activation of phosphoinositide 3-kinase is dependent on focal adhesion kinase.
Qi JH; Claesson-Welsh L
Exp Cell Res; 2001 Feb; 263(1):173-82. PubMed ID: 11161716
[TBL] [Abstract][Full Text] [Related]
17. Vascular endothelial cell growth factor promotes tyrosine phosphorylation of mediators of signal transduction that contain SH2 domains. Association with endothelial cell proliferation.
Guo D; Jia Q; Song HY; Warren RS; Donner DB
J Biol Chem; 1995 Mar; 270(12):6729-33. PubMed ID: 7896817
[TBL] [Abstract][Full Text] [Related]
18. Tyrosine phosphorylation of the vascular endothelial-growth-factor receptor-2 (VEGFR-2) is modulated by Rho proteins.
Gingras D; Lamy S; Béliveau R
Biochem J; 2000 Jun; 348 Pt 2(Pt 2):273-80. PubMed ID: 10816419
[TBL] [Abstract][Full Text] [Related]
19. Immediate and delayed VEGF-mediated NO synthesis in endothelial cells: role of PI3K, PKC and PLC pathways.
Gélinas DS; Bernatchez PN; Rollin S; Bazan NG; Sirois MG
Br J Pharmacol; 2002 Dec; 137(7):1021-30. PubMed ID: 12429574
[TBL] [Abstract][Full Text] [Related]
20. Dynamics of vascular endothelial-cadherin and beta-catenin localization by vascular endothelial growth factor-induced angiogenesis in human umbilical vein cells.
Wright TJ; Leach L; Shaw PE; Jones P
Exp Cell Res; 2002 Nov; 280(2):159-68. PubMed ID: 12413882
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
